CN102838647A - Hyodeoxycholic acid - Google Patents
Hyodeoxycholic acid Download PDFInfo
- Publication number
- CN102838647A CN102838647A CN2011101721386A CN201110172138A CN102838647A CN 102838647 A CN102838647 A CN 102838647A CN 2011101721386 A CN2011101721386 A CN 2011101721386A CN 201110172138 A CN201110172138 A CN 201110172138A CN 102838647 A CN102838647 A CN 102838647A
- Authority
- CN
- China
- Prior art keywords
- hyodeoxycholic acid
- thick
- water
- hyodeoxycholic
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The present invention discloses a hyodeoxycholic acid, which has the following structural formula. According to the present invention, two steps of a crude hyodeoxycholic magnesium extraction part (acidification, saponification, decoloration and precipitation) and a hyodeoxycholic acid purification part (acidification and crystallization) are adopted to obtain the refined hyodeoxycholic acid finished product, wherein a melting point of the hyodeoxycholic acid finished product can be 199-200 DEG C, a melting range is less than 2 DEG C, and content is more than 99%. According to the present invention, a production cycle is greatly shortened, a use amount of the organic solvent is less, and bile acid loss is not substantially generated in the whole process.
Description
Technical field
The invention belongs to Hyodeoxycholic Acid and preparation technology thereof.
Background technology
Hyodeoxycholic Acid, chemical name: 3 α, 6 alpha-dihydroxy-s-5 β-ursodeoxycholic acid, former name: hyodeoxycholic acid, structural formula is following:
Hyodeoxycholic Acid is a kind of ursodeoxycholic acid that from Fel Sus domestica, extracts, and can suppress the formation and the dissolved fat of cholic acid, reduces blood cholesterol and triglyceride level, is applicable to II a or IIb type hyperlipidemia, atherosclerosis.Bordetella pertussis, diphtheria corynebacterium, streptococcus aureus etc. there is certain bacteriostatic action.Can be used as antiphlogistic drug, treatment chronic bronchitis, child virus upper respiratory tract infection etc.These article can stimulate choleresis, make bile thinning and do not increase amount of solid, are applicable to biliary tract inflammation, cholecystitis, cholelithiasis and other nonobstructive cholestasis; Also can quicken cholecystic radiopoaque medium discharges liver and helps development.Still can promote enteron aisle steatolysis and liposoluble vitamin to absorb, can be used for the maldigestion that hepatobiliary disease causes.It also is the important component of preparation artificial Calculus Bovis.
The traditional technology of present domestic preparation Hyodeoxycholic Acid adopts acidifying after the saponification, dries again, receive the Hyodeoxycholic Acid bullion, again through ETHYLE ACETATE crystallization twice, crystal is after squeezing, fusing point just can reach more than 190 ℃.Production process is complicated, and the cycle is long, and the ETHYLE ACETATE consumption is big.
Summary of the invention
The object of the present invention is to provide that a kind of product purity is higher, production technique is simple, with short production cycle, Hyodeoxycholic Acid and preparation technology thereof that consumption of organic solvent is little.
The present invention is the Hyodeoxycholic Acid of formula,
The preparation technology of Hyodeoxycholic Acid of the present invention comprises the steps:
1) thick Hyodeoxycholic Acid magnesium extracts:
Get the Fel Sus domestica behind Fel Sus domestica filtrating or the heating and extracting UCB, add Hydrogen chloride and regulate PH to 3.0, promptly produce the thick bile acide deposition of tawny colloidal, leave standstill, the supernatant that inclines, thick bile acide, take out, water washes surperficial acid solution;
With the thick bile acide of sodium hydroxide saponification hydrolysis: the part by weight that feeds intake is thick bile acide: water: sodium hydroxide=1: 8: 1.5; Add water earlier by above-mentioned feed ratio when feeding intake, slowly add the sodium hydroxide stirring again and make dissolving, drop into thick bile acide again; Heated and boiled backflow saponification 24 hours; Be cooled to room temperature, upper strata buck layer is abandoned, and stays lower floor's gelatinous precipitate; Adding weight then is 10 times of water gagings of lower floor's gelatinous precipitate, and stirring and dissolving slowly adds ydrogen peroxide 50 again, makes Solution H
2O
2Weight percent concentration is 1~2%, decolours, filters filtrating excessively, and filtrating is heated to 50~60 ℃; Using concentration is that 10% dilute sulphuric acid is transferred PH8~9, and filtrating under agitation slowly adds 5.5% the sal epsom that its weight is Fel Sus domestica weight, filters; The collecting precipitation thing; Be Hyodeoxycholic Acid magnesium,, get thick Hyodeoxycholic Acid magnesium with water washing precipitate twice;
2) Hyodeoxycholic Acid is refining:
Get the thick Hyodeoxycholic Acid magnesium of step 1), be suspended in ETHYLE ACETATE and the water mixed solution by the following weight ratio that feeds intake and form suspension, the weight ratio that feeds intake is thick Hyodeoxycholic Acid magnesium: ETHYLE ACETATE: water=1: 4: 4; 50~60 ℃ of suspension heating, using weight percent concentration is that 10% dilute sulphuric acid is acidified to water layer PH=2, standing demix; Discard water layer, obtain ethyl acetate layer, filtered while hot; Crystallisation by cooling, crystal is collected in centrifuging; Crystal washs with amount of ethyl acetate, and drying through pulverizing, total mixed, packing, promptly gets purified Hyodeoxycholic Acid finished product, and the fusing point of Hyodeoxycholic Acid finished product can reach 199~200 ℃, and molten distance is less than 2 ℃, and content reaches more than 99%.
Advantage of the present invention: adopt new technology (1), directly adds the magnesium salts deposition after the saponification, forms Hyodeoxycholic Acid magnesium, and after the ETHYLE ACETATE crystallization, fusing point just can reach more than 195 ℃.Production cycle shortens greatly, and consumption of organic solvent is few.(2) product purity is higher: novel process receive the purity of the more former technology of Hyodeoxycholic Acid high; Its fusing point can reach 199~200 ℃; Molten distance is less than 2 ℃, and content reaches more than 99%, and the Hyodeoxycholic Acid fusing point that former explained hereafter goes out is generally 191~193; Impurity Chenodiol amount is bigger, and Fig. 1 carries out thin-layer chromatography relatively for the product of novel process and traditional technology production:
(3) the thick relatively bile acide yield of novel process is about 10%, and the traditional technology yield is about 15%, though yield has descended 5%; But saponification adds the Hyodeoxycholic Acid mother liquor of magnesium salts post precipitation; Through the recoverable again bile acide of acidifying, the master contains Chenodiol, can be applied on the feed; Also can further extract Chenodiol as the Chenodiol bullion.So basic free of losses of whole technological process bile acide.
Description of drawings
Fig. 1 carries out the thin-layer chromatography comparison diagram for the product of novel process of the present invention and traditional technology production.
Embodiment
Content of the present invention combines following examples to do explanation further, but content of the present invention is not limited only to content related among the embodiment.
The preparation technology of Hyodeoxycholic Acid of the present invention comprises the steps:
1) thick Hyodeoxycholic Acid magnesium extracts part (acidifying, saponification, decolouring, deposition):
Get Fel Sus domestica (manufacturer: Xiamen hundred million fragrant meats the are united processing ltd) 1000kg behind Fel Sus domestica filtrating or the heating and extracting UCB; Add Hydrogen chloride and regulate PH to 3.0, promptly produce the thick bile acide deposition of tawny colloidal, leave standstill; The supernatant that inclines, thick bile acide.Take out, water washes surperficial acid solution.
With the thick bile acide of sodium hydroxide saponification hydrolysis: the part by weight that feeds intake is thick bile acide: water: sodium hydroxide=1: 8: 1.5 feeds intake Xian Jiashui by the part by weight that feeds intake; Slowly add the sodium hydroxide stirring again and make dissolving, drop into thick bile acide again, heated and boiled refluxes; Saponification 24 hours; Be cooled to room temperature, upper strata buck layer is abandoned, and stays lower floor's gelatinous precipitate.Adding weight then is 10 times of water gagings of lower floor's gelatinous precipitate, and stirring and dissolving slowly adds ydrogen peroxide 50 again, makes Solution H
2O
2Concentration is 1.5% (weight percent), decolours 12 hours, crosses and filters filtrating; Filtrating is heated to 55 ℃, transfers PH8.5 with dilute sulphuric acid (weight percent concentration is 10%), and filtrating under agitation slowly adds the sal epsom that its weight is 5.5% (weight percent concentration) of Fel Sus domestica weight; Filter, the collecting precipitation thing is Hyodeoxycholic Acid magnesium; With water washing precipitate twice, get thick Hyodeoxycholic Acid magnesium.
2) Hyodeoxycholic Acid FF (acidifying, crystallization):
Get thick Hyodeoxycholic Acid magnesium, be suspended in ETHYLE ACETATE and water by mixed solution in, the part by weight that feeds intake is thick Hyodeoxycholic Acid magnesium: ETHYLE ACETATE: water=1: 4: 4; 55 ℃ of suspension heating are acidified to water layer PH=2, standing demix with dilute sulphuric acid (weight percent concentration is 10%); Discard water layer, obtain ethyl acetate layer, filtered while hot; Crystallisation by cooling, crystal is collected in centrifuging.Crystal washs with amount of ethyl acetate, and drying through pulverizing, total mixed, packing, promptly gets purified Hyodeoxycholic Acid finished product, and its fusing point can reach 199~200 ℃, and molten distance is less than 2 ℃, and content reaches more than 99%.
Claims (2)
2. the preparation technology of a Hyodeoxycholic Acid comprises the steps:
1) thick Hyodeoxycholic Acid magnesium extracts:
Get the Fel Sus domestica behind Fel Sus domestica filtrating or the heating and extracting UCB, add Hydrogen chloride and regulate PH to 3.0, promptly produce the thick bile acide deposition of tawny colloidal, leave standstill, the supernatant that inclines, thick bile acide, take out, water washes surperficial acid solution;
With the thick bile acide of sodium hydroxide saponification hydrolysis: the part by weight that feeds intake is thick bile acide: water: sodium hydroxide=1: 8: 1.5; Add water earlier by above-mentioned feed ratio when feeding intake, slowly add the sodium hydroxide stirring again and make dissolving, drop into thick bile acide again; Heated and boiled backflow saponification 24 hours; Be cooled to room temperature, upper strata buck layer is abandoned, and stays lower floor's gelatinous precipitate; Adding weight then is 10 times of water gagings of lower floor's gelatinous precipitate, and stirring and dissolving slowly adds ydrogen peroxide 50 again, makes Solution H
2O
2Weight percent concentration is 1~2%, decolours, filters filtrating excessively, and filtrating is heated to 50~60 ℃; Using concentration is that 10% dilute sulphuric acid is transferred PH8~9, and filtrating under agitation slowly adds 5.5% the sal epsom that its weight is Fel Sus domestica weight, filters; The collecting precipitation thing; Be Hyodeoxycholic Acid magnesium,, get thick Hyodeoxycholic Acid magnesium with water washing precipitate twice;
2) Hyodeoxycholic Acid is refining:
Get the thick Hyodeoxycholic Acid magnesium of step 1), be suspended in ETHYLE ACETATE and the water mixed solution by the following weight ratio that feeds intake and form suspension, the weight ratio that feeds intake is thick Hyodeoxycholic Acid magnesium: ETHYLE ACETATE: water=1: 4: 4; 50~60 ℃ of suspension heating, using weight percent concentration is that 10% dilute sulphuric acid is acidified to water layer PH=2, standing demix; Discard water layer, obtain ethyl acetate layer, filtered while hot; Crystallisation by cooling, crystal is collected in centrifuging; Crystal washs with amount of ethyl acetate, and drying through pulverizing, total mixed, packing, promptly gets purified Hyodeoxycholic Acid finished product, and the fusing point of Hyodeoxycholic Acid finished product can reach 199~200 ℃, and molten distance is less than 2 ℃, and content reaches more than 99%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101721386A CN102838647A (en) | 2011-06-23 | 2011-06-23 | Hyodeoxycholic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101721386A CN102838647A (en) | 2011-06-23 | 2011-06-23 | Hyodeoxycholic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102838647A true CN102838647A (en) | 2012-12-26 |
Family
ID=47366399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101721386A Pending CN102838647A (en) | 2011-06-23 | 2011-06-23 | Hyodeoxycholic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102838647A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106279333A (en) * | 2016-08-04 | 2017-01-04 | 神威药业集团有限公司 | A kind of Hyodeoxycholic Acid crystallization processes method of optimization |
CN106977573A (en) * | 2017-06-06 | 2017-07-25 | 福建省仙游县南丰生化有限公司 | Hyodesoxycholic acid, the joint generation of chenodeoxycholic acid, purification process |
CN114315948A (en) * | 2021-12-29 | 2022-04-12 | 福建省南仹生物科技有限公司 | Method for extracting hyodeoxycholic acid from pig bile paste |
CN115850362A (en) * | 2022-12-30 | 2023-03-28 | 上海雷允上药业有限公司 | Method for preparing hyodeoxycholic acid extract |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1830996A (en) * | 2006-04-17 | 2006-09-13 | 常德云港生物科技有限公司 | Method for preparing chenodeoxycholic acid |
CN101037463A (en) * | 2007-04-11 | 2007-09-19 | 江苏大学 | Method for preparing high-purity hyodeoxycholic acid by pig bile |
CN101215308A (en) * | 2007-01-04 | 2008-07-09 | 苏州天绿生物制药有限公司 | Method for producing ursodeoxycholic acid by using swine bladder as raw material |
-
2011
- 2011-06-23 CN CN2011101721386A patent/CN102838647A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1830996A (en) * | 2006-04-17 | 2006-09-13 | 常德云港生物科技有限公司 | Method for preparing chenodeoxycholic acid |
CN101215308A (en) * | 2007-01-04 | 2008-07-09 | 苏州天绿生物制药有限公司 | Method for producing ursodeoxycholic acid by using swine bladder as raw material |
CN101037463A (en) * | 2007-04-11 | 2007-09-19 | 江苏大学 | Method for preparing high-purity hyodeoxycholic acid by pig bile |
Non-Patent Citations (2)
Title |
---|
俞长芳: "胆汁的化学与应用(续三)", 《中国生化药物杂志》 * |
王健等: "单手性臂α-猪去氧胆酸类分子钳的设计与微波合成", 《应用化学》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106279333A (en) * | 2016-08-04 | 2017-01-04 | 神威药业集团有限公司 | A kind of Hyodeoxycholic Acid crystallization processes method of optimization |
CN106977573A (en) * | 2017-06-06 | 2017-07-25 | 福建省仙游县南丰生化有限公司 | Hyodesoxycholic acid, the joint generation of chenodeoxycholic acid, purification process |
CN114315948A (en) * | 2021-12-29 | 2022-04-12 | 福建省南仹生物科技有限公司 | Method for extracting hyodeoxycholic acid from pig bile paste |
CN115850362A (en) * | 2022-12-30 | 2023-03-28 | 上海雷允上药业有限公司 | Method for preparing hyodeoxycholic acid extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100556914C (en) | A kind of method that from Fel Sus domestica, prepares the high purity Hyodeoxycholic Acid | |
CN101215308B (en) | Method for producing ursodeoxycholic acid by using swine bladder as raw material | |
CN102321122B (en) | Method for preparing sucralose from sucralose-6-acetate | |
CN102838647A (en) | Hyodeoxycholic acid | |
CN102766185B (en) | Method for respectively recovering ursodesoxycholic acid and chenodeoxycholic acid from ursodesoxycholic acid waste mother liquor | |
CN1830996A (en) | Method for preparing chenodeoxycholic acid | |
CN102604747A (en) | Technique for producing alpha-linoleic acid, silkworm pupa protein and silkworm pupa peptides with silkworm pupas | |
CN102718829B (en) | The preparation method of TUDCANa | |
CN102863497B (en) | Hyodeoxycholic acid refining method | |
CN103804453B (en) | The method preparing ursodesoxycholic acid for raw material with Fel Sus domestica | |
CN102887885B (en) | Preparation method of esomeprazole sodium | |
CN102911234A (en) | Method for producing chenodeoxycholic acid by using chicken bile as raw material | |
CN111635308B (en) | Method for co-producing and preparing linoleic acid and alpha-linolenic acid from idesia polycarpa seed oil | |
CN101289488A (en) | Preparation process of deoxycholeic acid of bear | |
CN102887821A (en) | Method for extracting DHA (docosahexaenoic acid) through extraction and separation of marine microalgae fermentation liquid | |
CN105481927A (en) | Method for extracting cholic acid of ducks and chenodeoxycholic acid (CDCA) from bile of ducks | |
CN103113294A (en) | Synthesizing method of rebamipide | |
CN102617461A (en) | Novel method for refining aripiprazole | |
CN104109182B (en) | A kind of method preparing gemcitabine hydrochloride | |
CN105481926A (en) | Method for directly preparing chenodeoxycholic acid from duck bile | |
CN103483404B (en) | A kind of method of hesperidine of purifying from tangerine slag | |
CN103539828A (en) | Method of extracting hyodeoxycholic acid from leftovers of pig bile without bilirubin | |
CN102492000A (en) | Method for preparing D-glucosamine hydrochloride | |
CN102675079B (en) | Recovery method of aliphatic calcium alpha-keto acid | |
CN106279333B (en) | A kind of hyodesoxycholic acid crystallization processes method of optimization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121226 |